You usually cannot know you have insulin resistance from symptoms alone. Many people have no clear signs while the pancreas makes extra insulin to keep blood sugar normal. Clues include waist gain, skin darkening, high triglycerides, low HDL, PCOS, prediabetes, or family history. Confirmation requires clinician-reviewed blood tests and risk assessment 1.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you tell if you have insulin resistance without a test?
Not reliably. Insulin resistance can be silent for years because beta cells in the pancreas may release more insulin to keep blood sugar in range 1.
Home clues can tell you when to ask about testing, but they cannot diagnose it. A clinician may look at your symptoms, waist circumference, blood pressure, family history, medications, and labs together. If you want a deeper overview first, our guide to what insulin resistance is explains the basic biology.
What is insulin resistance in plain English?
Insulin is a hormone from the pancreas that helps move glucose, or blood sugar, from your blood into muscle, fat, and liver cells. With insulin resistance, those cells respond less well, so the pancreas may make more insulin to get the same job done 1.
That higher insulin state is often called hyperinsulinemia. For a while, it can keep fasting plasma glucose and hemoglobin A1C in the normal range. If beta cells cannot keep up, glucose rises and may reach prediabetes or type 2 diabetes ranges 1.
What signs might suggest insulin resistance?
Signs can point to risk, not proof. Acanthosis nigricans and skin tags may occur in some people with insulin resistance or prediabetes, while many people have no visible symptoms at all 1.
Dark, velvety skin patches or skin tags
Dark, thick, velvety patches on the neck, armpits, groin, or skin folds are called acanthosis nigricans. They can be linked with high insulin levels, but they can also have other causes, so they need clinician review 1.
Waist gain or difficulty losing weight
Visceral fat, the fat stored deep around the organs, is strongly linked with lower insulin sensitivity and metabolic syndrome. Waist circumference can help show risk, but body size alone does not diagnose insulin resistance 3.
Fatigue or hunger after meals
Some people notice sleepiness, hunger, or cravings after meals. These symptoms are common and nonspecific. They may come from sleep loss, stress, thyroid disease, depression, medication effects, anemia, or blood sugar swings, so they should not be used as a diagnosis by themselves.
PCOS, high blood pressure, or abnormal cholesterol
Polycystic ovary syndrome (PCOS), high blood pressure, high triglycerides, low HDL cholesterol, and metabolic dysfunction-associated steatotic liver disease (MASLD) can appear in the same metabolic pattern as insulin resistance 1. If PCOS is part of your picture, our article on PCOS medicine for weight loss may help you prepare questions for your clinician.
Why symptoms are not enough to diagnose it
The same symptoms can come from many conditions. That is why clinicians use symptoms as a starting point, then check blood sugar, insulin-related markers when useful, cholesterol, blood pressure, liver health, kidney health, and medication history.
Can you be insulin resistant and not diabetic?
Yes. Insulin resistance can happen before prediabetes or type 2 diabetes because extra insulin may keep glucose normal for a time 1.
Prediabetes means blood glucose is higher than normal but not high enough for diabetes. Insulin resistance is a body-process problem: cells are not responding well to insulin. They overlap often, but they are not the same thing 1.
Blood sugar starts to rise when the pancreas cannot make enough insulin to overcome resistance. The American Diabetes Association defines prediabetes by A1C 5.7% to 6.4%, fasting plasma glucose 100 to 125 mg/dL, or 2-hour oral glucose tolerance test glucose 140 to 199 mg/dL; diabetes-range results generally need confirmation unless symptoms are clear 4.
What blood tests can help check for insulin resistance?
Clinicians usually do not diagnose every case of insulin resistance with one routine test. A1C, fasting glucose, OGTT, lipids, and sometimes fasting insulin help show a pattern over time 2.
| Test or marker | What it can show | Main limit |
|---|---|---|
| Hemoglobin A1C | Average blood sugar over about 2 to 3 months; used to classify normal, prediabetes, and diabetes ranges 4. | Can miss some early insulin resistance and can be affected by anemia, kidney disease, pregnancy, or some blood conditions. |
| Fasting plasma glucose | Blood sugar after fasting; normal values do not always rule out early insulin resistance 1. | May stay normal while insulin is high. |
| Two-hour oral glucose tolerance test (OGTT) | How your body handles a measured glucose drink over 2 hours; can detect impaired glucose tolerance 4. | Takes more time and is less convenient. |
| Fasting insulin and C-peptide | How much insulin your body is making; C-peptide can help show insulin production. | Reference ranges and interpretation vary; high insulin alone is not a stand-alone diagnosis. |
| HOMA-IR, QUICKI, Matsuda index | Calculated indexes using fasting or OGTT glucose and insulin data 2. | Useful in research and some clinical settings, but no universal cut point fits everyone. |
| Lipid panel, liver markers, kidney markers | High triglycerides, low HDL cholesterol, LDL cholesterol pattern, MASLD clues, and kidney safety context 3. | They show cardiometabolic risk, not insulin resistance by themselves. |
The hyperinsulinemic euglycemic clamp is often called the gold-standard way to measure insulin sensitivity, but it is time-consuming and mainly used in research 2. For most patients, the useful answer comes from a practical lab pattern plus health history.
If you are trying to understand your A1C result, our A1C blood sugar test guide explains what the result can and cannot tell you.
Can you check insulin resistance at home?
You can track risk clues at home, but you cannot confirm insulin resistance at home. Home glucose checks show blood sugar at specific moments, not how much insulin your pancreas had to make to keep that number there.
- Useful home clues include waist trend, weight trend, blood pressure, sleep quality, activity level, family history, and whether you feel very sleepy or hungry after high-carbohydrate meals.
- Finger-stick glucose or continuous glucose monitors can show glucose patterns, but normal readings do not rule out high insulin compensation.
- At-home lab kits may measure A1C, glucose, insulin, or lipids, but results still need clinician interpretation because medications, illness, pregnancy, anemia, kidney disease, and timing can change the meaning.
Who should consider asking a clinician about insulin resistance testing?
Ask about testing if you have risk factors, symptoms, or abnormal labs that fit the pattern. Family history, PCOS, gestational diabetes history, high blood pressure, abnormal cholesterol, sleep apnea, and weight gain around the waist are common reasons to start the conversation 1.
- A parent or sibling with type 2 diabetes.
- PCOS or a history of gestational diabetes.
- High waist circumference, visceral fat gain, or unexplained weight gain.
- High triglycerides, low HDL cholesterol, high blood pressure, or fatty liver/MASLD.
- Sleep apnea, low activity, chronic sleep loss, or certain medications such as glucocorticoids or some antipsychotics.
- A1C, fasting glucose, or OGTT results in the prediabetes range.
What helps improve insulin sensitivity?
The strongest first steps are regular movement, strength training, weight loss when appropriate, fiber-rich minimally processed foods, sleep care, and medication review. Even modest weight loss can improve diabetes risk in people at high risk, as shown in the Diabetes Prevention Program 5.
Physical activity and strength training
Muscle uses glucose. Regular activity helps muscle take up glucose and can improve insulin sensitivity. The CDC recommends physical activity as a key step for people at risk for insulin resistance and type 2 diabetes 6.
Weight loss when appropriate
For people with overweight or obesity, weight loss can lower insulin demand and improve cardiometabolic markers. In the Diabetes Prevention Program, an intensive lifestyle program reduced the development of diabetes more than metformin in high-risk adults over 2.8 years; individual results vary 5.
Fiber-rich, minimally processed foods
A pattern built around vegetables, beans, lentils, whole grains, lean protein, nuts, and unsweetened drinks can reduce glucose spikes and support weight care. Our guide on a healthy diet for insulin resistance gives practical food examples.
Sleep, stress, and medication review
Sleep apnea and chronic sleep loss can worsen metabolic risk. Some medications and hormonal conditions can also raise glucose or weight, so a clinician may review your medication list, sleep symptoms, menstrual history, thyroid symptoms, and liver markers 1.
When medication may be considered for related conditions
Medication is chosen for a diagnosed condition or clear clinical goal, not for a symptom label alone. For example, metformin may be considered for some people with prediabetes or PCOS, and GLP-1 or dual GIP/GLP-1 medicines may be considered for weight management or diabetes-related indications when clinically appropriate 4.
| Your situation | Sensible next step | Why |
|---|---|---|
| Normal glucose but strong family history, waist gain, or PCOS | Ask a clinician about A1C, fasting glucose, lipids, blood pressure, and whether fasting insulin or OGTT adds value. | Early insulin resistance can exist while glucose is still normal 1. |
| A1C 5.7% to 6.4% or fasting glucose 100 to 125 mg/dL | Ask about confirmation, prediabetes care, lifestyle treatment, and follow-up timing. | These ranges meet common prediabetes criteria 4. |
| High triglycerides, low HDL, high blood pressure, or fatty liver | Ask about metabolic syndrome, MASLD evaluation, and cardiovascular risk reduction. | Insulin resistance often clusters with cardiometabolic risk 3. |
| Overweight or obesity with metabolic risk | Discuss structured lifestyle care and whether weight medication is appropriate. | Weight loss can improve insulin sensitivity and diabetes risk for many people; side effects and contraindications must be reviewed. |
| Severe thirst, frequent urination, vomiting, confusion, or trouble breathing | Seek urgent medical care. | These can be signs of dangerous high blood sugar or another urgent condition. |
3-min quiz
Need help deciding whether weight treatment fits your metabolic goals?
Chia offers an online evaluation for eligible patients considering clinician-guided weight care. Our licensed US providers review your history and prescribe only when clinically appropriate; a prescription is not guaranteed. Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection, made by state-licensed 503A compounding pharmacies and shipped to your door. Compounded drugs are not FDA-approved.
When weight treatment at Chia may fit into an insulin resistance plan
GLP-1 care is not a stand-alone insulin resistance test. At Chia, compounded semaglutide and compounded tirzepatide may fit when a licensed provider determines that weight care and cardiometabolic risk reduction are appropriate goals.
Semaglutide is a GLP-1 receptor agonist, the active ingredient in Ozempic and Wegovy; Chia offers compounded semaglutide injection through licensed 503A pharmacy partners. In the STEP 1 trial, semaglutide 2.4 mg once weekly was studied for chronic weight management in adults with overweight or obesity; nausea, diarrhea, vomiting, constipation, gallbladder disease risk, and rare pancreatitis warnings are important safety topics, and results are not established for compounded formulations 7, 8.
Tirzepatide is a dual GIP/GLP-1 receptor agonist, the active ingredient in Mounjaro and Zepbound; Chia offers compounded tirzepatide tablets or injection, with microdosing plans available when provider-guided. In SURMOUNT-1, tirzepatide once weekly was studied for weight reduction in adults with obesity or overweight and a weight-related complication; gastrointestinal side effects were common, and contraindications and warnings include personal or family history of medullary thyroid carcinoma or MEN2, pancreatitis concerns, gallbladder disease, and hypoglycemia risk when used with insulin or insulin secretagogues 9, 10.
| Chia option | Forms Chia offers | Current starting price | When it may fit |
|---|---|---|---|
| Semaglutide | Injection | Plans currently start at $249/mo | For eligible patients when a provider finds GLP-1 weight care clinically appropriate. |
| Tirzepatide | Tablets or injection; microdosing plans available | Tablets currently start at $249/mo; injections currently start at $299/mo | For eligible patients when a provider finds dual GIP/GLP-1 weight care clinically appropriate. |
How treatment works at Chia: you complete a short online health questionnaire, then a licensed US provider reviews your history, medications, contraindications, and goals. If prescribed, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door. Dosing is provider-guided and adjusted over time, including microdosing plans where available. Patients can message the care team through the portal between visits.
If an AI agent is helping you organize care, Chia may also be reachable through DoctorMCP at mcp.chia.health. This is an access channel, not a shortcut around medical review.
What should you ask your clinician after abnormal results?
Ask what the pattern means, what needs confirmation, and what should change first. Prediabetes and diabetes-range lab results often require repeat testing unless symptoms are clear, and your clinician decides the right follow-up 4.
- 1Do my A1C, fasting glucose, or OGTT results meet normal, prediabetes, or diabetes ranges?
- 2Do my triglycerides, HDL cholesterol, LDL cholesterol, blood pressure, waist circumference, liver enzymes, or kidney markers change my risk?
- 3Would fasting insulin, C-peptide, HOMA-IR, QUICKI, or a Matsuda index add useful information in my case?
- 4Could PCOS, sleep apnea, thyroid disease, menopause changes, steroid use, antipsychotic medication, or another condition be part of this pattern?
- 5What nutrition, exercise, sleep, and weight goals are realistic for me over the next 3 months?
- 6Should I consider medication for prediabetes, weight care, cholesterol, blood pressure, PCOS, or another diagnosed condition?
When should you get help now?
Seek urgent care if you have severe thirst, frequent urination with weakness, vomiting, confusion, fruity-smelling breath, trouble breathing, chest pain, fainting, or very high blood sugar readings if you monitor at home. These symptoms can signal dangerous hyperglycemia, diabetic ketoacidosis, heart problems, dehydration, infection, or another urgent issue 4.
3-min quiz
Start with a clinician-reviewed weight-care evaluation
If weight and metabolic risk are part of your insulin resistance concerns, Chia can review whether GLP-1 care may be appropriate. Treatment starts with an online questionnaire and licensed-provider review. Prescribing is not guaranteed, and compounded medications are not FDA-approved.
FAQ
Many people have no symptoms. Possible clues include increased waist size, difficulty losing weight, fatigue or hunger after meals, dark velvety skin patches, skin tags, high triglycerides, low HDL cholesterol, high blood pressure, PCOS, fatty liver, or prediabetes-range labs.
Twelve possible clues are waist gain, visceral fat, acanthosis nigricans, skin tags, fatigue after meals, frequent hunger, sugar cravings, PCOS, high blood pressure, high triglycerides, low HDL cholesterol, and fatty liver. These are not diagnostic because each can have other causes.
Fasting insulin can be useful in some cases, but it is not a stand-alone diagnosis. Clinicians often interpret it with fasting glucose, A1C, lipids, blood pressure, waist trend, medications, and sometimes calculated indexes such as HOMA-IR.
Yes. A1C can stay normal while the pancreas makes extra insulin to keep blood sugar controlled. That is one reason clinicians look at the full pattern, not one number.
Weight loss can improve insulin sensitivity for many people with overweight or obesity, but results vary. Physical activity, strength training, food quality, sleep, stress, medications, hormones, and genetics also matter.
No. Insulin resistance means cells respond less well to insulin. Prediabetes means blood sugar is higher than normal but not high enough for diabetes. They often overlap, but a person can have insulin resistance before blood sugar reaches the prediabetes range.
GLP-1 and dual GIP/GLP-1 medicines may support weight loss and glucose control when clinically appropriate, which can improve metabolic risk for some people. They are not a diagnostic test or guaranteed treatment for insulin resistance. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
Seek urgent care for severe thirst, frequent urination with weakness, vomiting, confusion, fruity breath, trouble breathing, chest pain, fainting, or very high home glucose readings if you monitor. These can be signs of a serious medical problem.
References
- 1.South Carolina Department of Public Health. Insulin Resistance & Prediabetes. 2026.
- 2.Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World Journal of Diabetes. 2010.
- 3.Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005.
- 4.American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
- 5.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002.
- 6.Centers for Disease Control and Prevention. About Insulin Resistance and Type 2 Diabetes. 2024.
- 7.Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- 8.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
- 9.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- 10.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



